RLMD Relmada Therapeutics, Inc. Buxgalteriya kapitallashuvi

Ommaviy kompaniya Relmada Therapeutics, Inc. (RLMD) logotipi

Relmada Therapeutics (RLMD) taqdiri bevosita uning R&D loyihalari muvaffaqiyati va kapital xarajatlar samaradorligiga bog'liq, chunki hozirda barqaror daromad mavjud emas va ko'rsatkich 0.21 darajasida turibdi. Biznes psixiatrik buzilishlar va markaziy nerv tizimi (CNS) patologiyalari uchun zamonaviy terapiyalarni ishlab chiqishga tayanadi. Ushbu narxlar grafigi turli davolash rejimlari bo'yicha NMDA retseptor antagonistlarini sinovdan o'tkazish orqali xatarlari yumshatilgan aktivning kotirovkalarini aks ettiradi.

RLMD Relmada Therapeutics, Inc. Balans kapitallashuvi (04.07.2022 - 27.10.2026)

Relmada Therapeutics, Inc. (RLMD) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Relmada Corp|RLMD - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Relmada Therapeutics Inc|RLMD - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Relmada Therapeutics|RLMD - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti relmada.com|RLMD - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Relmada Therapeutics|RLMD - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Relmada Therapeutics Inc|RLMD - Kompaniya qarzlari|Balans qiymatiga qarzlar Relmada Therapeutics Inc
Kompaniyaning jamlanma tahlili:Relmada Corp - RLMD
Relmada Therapeutics Inc yetakchi tovari

Yuqori sifatli aktivlarni tanlash uchun investor bozor shovqinlarini hisobga olmagan holda, haqiqiy sof aktivlar qiymatiga tayanishi kerak. Joriy 0.21 ko'rsatkichi Relmada Therapeutics (RLMD) kompaniyasining haqiqiy kapitalini aks ettiradi, bu esa REL-1017 dori vositasini ishlab chiqish davrida moliyaviy barqarorlikni baholash uchun juda muhimdir, shu bilan birga, kitob kapitalizatsiyasining tebranishlari biofarmatsevtika sektoridagi soxta o'sish impulslarini o'z vaqtida aniqlash imkonini beradi.

Relmada Therapeutics raqobatchilari

BIIB - Kompaniyaning sof aktivlari|Balans kapitallashuvi Neurocrine Biosciences|RGC (regencellbioscience.com) - Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|AMLX (Amylyx Corp) - Kompaniyaning xususiy kapitali|TRVI - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati praxismedicines.com|Anavex Life Sciences Corp. - Balans kapitallashuvi|Kompaniyaning xususiy kapitali CBLL (CeriBell Inc)|Kompaniyaning balans qiymati prothena.com PRTA|Alector Inc. - Kompaniyaning balans qiymati|ANNX: Kompaniyaning balans qiymati|OMER - Kompaniyaning sof aktivlari|NGNE: Balans kapitallashuvi|AC Immune S.A. (ACIU) - Balans kapitallashuvi|Balans kapitallashuvi Voyager Pharma (VYGR)|Buxgalteriya kapitallashuvi Neumora Corp|Balans kapitallashuvi SCLX|Balans kapitallashuvi tevogen.com TVGN|Kompaniyaning sof aktivlari Alpha Cognition Inc.|CGTX - Kompaniyaning buxgalteriya qiymati|Kompaniyaning sof aktivlari Inhibikase IKT|SAVA - Jami sof aktivlar|Balans kapitallashuvi assertiotx.com ASRT|Coya Therapeutics (COYA) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi VTGN (VistaGen Therapeutics, Inc.)|Kompaniyaning xususiy kapitali OVID|Acumen Pharma (ABOS) - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati CervoMed Corporation (CRVO)|Balans kapitallashuvi ATHE (Alterity Therapeutics Limited)|Clene Inc - Balans kapitallashuvi|Kompaniyaning balans qiymati PepGen Corp|JUNS - Sof aktivlar qiymati|Balans kapitallashuvi ANVS|Kompaniyaning xususiy kapitali Grace Therapeutics|AIFF (Firefly Neuroscience, Inc) - Kompaniyaning sof aktivlari|Balans kapitallashuvi ANEW Medical, Inc. (KLTO)|Kompaniyaning sof aktivlari NeuroSense Therapeutics|Jami sof aktivlar Reviva Pharmaceuticals Holdings Inc. (RVPH)|Balans kapitallashuvi MTVA|Biznesning balans bahosi NeurAxis Inc NRXS|HSDT: Balans kapitallashuvi|PASG: Kompaniyaning sof aktivlari|bionomics.com.au - Kompaniyaning balans qiymati|NERV (Minerva Neurosciences Inc) - Biznesning balans bahosi|ATHA - Kompaniyaning balans qiymati|Kompaniyaning buxgalteriya qiymati ADXN|Kompaniyaning balans qiymati Alzamend Neuro, Inc. (ALZN)|Kompaniyaning balans qiymati CYCN (cyclerion.com)|Protagenic Therapeutics, Inc. - Kompaniyaning balans qiymati|Kompaniyaning sof aktivlari Pasithea Therapeutics Corp KTTA|Cortigent Medical (CRGT) - Balans kapitallashuvi|ATXI: Buxgalteriya kapitallashuvi|Kompaniyaning balans qiymati Brainstorm Cell|caratherapeutics.com (CARA) - Buxgalteriya kapitallashuvi|Balans kapitallashuvi CHRO (Chromocell Therapeutics Corp.)|Kompaniyaning xususiy kapitali Eliem (ELYM)|Kompaniyaning sof aktivlari ITCI|Balans kapitallashuvi LBPH (Longboard)|Kompaniyaning balans qiymati Marinus Pharmaceuticals|nkgenbiotech.com - Kompaniyaning buxgalteriya qiymati|NRBO (NeuroBo Pharmaceuticals, Inc.) - Kompaniyaning balans qiymati|SAGE: Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Neurotrope SNPX|Trevena Inc (TRVN) - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi VIGL (Vigil Neuroscience Inc.)|Kompaniyaning xususiy kapitali WENA|Kompaniyaning balans qiymati Cerevel Therapeutics, Inc. (CERE)